Efficacy, Safety evaluation and GMP development of lentiviral vector-induced multivalent dendritic cells for melanoma immunotherapy (2011)

First Author: Stripecke R.
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 22

Parent Publication: HUMAN GENE THERAPY

Issue: 10

ISSN: 1043-0342